NCT04764201View on ClinicalTrials.gov

The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 16, 2021

Primary Completion Date

February 26, 2021

Study Completion Date

March 8, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

HIP2001

Test drug

DRUG

HGP2001

Reference drug

Trial Locations (1)

Unknown

Jeonbuk University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04764201 - The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter